Table 4

Clinical characteristics of patients with and without overexpression of c-erbB2 and topoisomerase II╬▒

Parameter

Value


Topoisomerase overexpression

Absent

Absent

Present

Present

c-erb B2 overexpression

Absent

Present

Absent

Present


Stage, n (%)

I

29 (24.2)

3 (15.0)

6 (11.1)

2 (10.0)

II

59 (49.1)

7 (35.0)

36 (66.6)

11 (55.0)

III

29 (24.2)

9 (45.0)

9 (16.7)

6 (30.0)

IV

3 (2.5)

1 (5)

3 (5.6)

1 (5.0)

Totala

120

20

54

20

Receptor status, n (%)

ER or PR positive

92 (79.3)

12 (57.1)

32 (58.2)

10 (52.6)

PR and PR negative

24 (20.7)

9 (42.9)

23 (41.8)

9 (47.4)

Totalb

116

21

55

19


a214 patients with complete data were analyzed for stage; b211 patients with complete data were analyzed for receptor status. ER, estrogen receptor; PR, progesterone receptor.

Fritz et al. Breast Cancer Research 2005 7:R374-R384   doi:10.1186/bcr1012

Open Data